Rolf F Barth
机构: Professor of Pathology, The Ohio State University
每年引用次数
引用次数
引用: 19,450
H-指数: 67
I10-指数 : 234
出版物: 517
The effect of epidermal growth factor receptor (EGFR) expression on in vivo growth of rat C6 glioma cells.
R. A. Fenstermaker , J. Capala , Hsing-Jien Kung , D. M. Kaetzel
Leukemia 9
17
1995
Cell survival experiments for bnct at the osu research reactor, invited
B. Khorsandi , R. F. Barth , V. Krishnan , T. E. Blue
Transactions of the American Nuclear Society 97 312 -313
2007
The development of carboranyl nucleic acid precursors for use in neutron capture therapy of tumors
A. H. Soloway , A. K. M. Anisuzzaman , F. Alam , R. F. Barth
Pure and Applied Chemistry 63 ( 3) 411 -413
14
1991
Boron Compounds for Neutron Capture Therapy
F. Alam , A. H. Soloway , B. V. Bapat , R. F. Barth
Clinical Aspects of Neutron Capture Therapy 165 107 -111
21
1989
Delayed Effects of Neutron Irradiation on Central Nervous System Microvasculature in the Rat
J. H. Goodman , J. M. McGregor , N. R. Clendenon , W. A. Gordon
Clinical Aspects of Neutron Capture Therapy 50 87 -93
1989
Adaptation of the hemolytic plaque technique for enumeration of immune cells responding to heterologous immunoglobulin antigens.
R. F. Barth , B. Merchant
Experimental Biology and Medicine 125 ( 1) 307 -309
3
1967
Tumor Targeting Agents for Neutron Capture Therapy
A. H. Soloway , F. Alam , R. F. Barth , A. K. M. Anisuzzaman
Neutron Beam Design, Development, and Performance for Neutron Capture Therapy 54 37 -47
6
1990
Molecular Targeting and Treatment of an Epidermal Growth Factor Receptor–Positive Glioma Using Boronated Cetuximab
G. Wu , W. Yang , R. F. Barth , S. Kawabata
Clinical Cancer Research 13 ( 4) 1260 -1268
134
2007
A new radioisotopic microassay of cell-mediated immunity utilizing technetium-99m labeled target cells.
G. Y. Gillespie , R. F. Barth , A. Gobuty
Experimental Biology and Medicine 142 ( 2) 378 -382
5
1973
A radioisotopic microassay for lymphotoxin using technetium-99 labeled cells.
R. F. Barth , G. Y. Gillespie , W. Rosenau
Experimental Biology and Medicine 144 ( 2) 564 -568
3
1973
Alterations in the immunogenicity and antigenicity of mammalian erythrocytes following treatment with neuraminidase.
R. F. Barth , O. Singla
Experimental Biology and Medicine 145 ( 1) 168 -172
5
1974
Synthesis and Biological Evaluation of Boronated Folates for BNCT
S. Shukla , J. Sudimack , D. Adams , G. Wu
ChemInform 35 ( 29)
2004
Injection of cells and monoclonal antibodies into mice: comparison of tail vein and retroorbital routes
J. E. Price , R. F. Barth , C. W. Johnson , A. E. Staubus
Experimental Biology and Medicine 177 ( 2) 347 -353
27
1984
Distinct and non-cross-reactive epitopes are recognized on B16 melanoma by LAK cells and anti-B16 monoclonal antibodies.
J.-J. Tzeng , R. F. Barth , C. W. Johnson , D. M. Adams
Experimental Biology and Medicine 193 ( 4) 285 -292
1
1990
Alterations in monoclonal antibody affinity and antigenic receptor site expression on mycoplasma-infected human colorectal cancer cells.
O. A. Oredipe , R. F. Barth , J. H. Rotaru , G. H. Hinkle
Experimental Biology and Medicine 194 ( 4) 301 -307
7
1990
Binding of Boronated Polylysine to Immunoglobulin by Way of Glycoside Moieties: Immunoreactivity and Boron Content
S. Novick , M. R. Quastel , S. Marcus , D. Chipman
Advances in Neutron Capture Therapy 357 -360
4
1993
Treatment of Intracerebral Malignant Melanoma Using a Rat Model and L-Boronophenylalanine as the Capture Agent
M. Q. Bailey , K. Z. Matalka , R. F. Barth , J. A. Coderre
Advances in Neutron Capture Therapy 519 -523
1993
Tumoricidal activity of low-energy 160-KV versus 6-MV X-rays against platinum-sensitized F98 glioma cells
S. N. Lim , A. K. Pradhan , R. F. Barth , S. N. Nahar
Journal of Radiation Research 56 ( 1) 77 -89
12
2015
Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors
R. F. Barth , W. Yang , G. Wu , M. Swindall
Proceedings of the National Academy of Sciences of the United States of America 105 ( 45) 17493 -17497
43
2008
Boron Neutron Capture Therapy of Brain Tumors: Targeting Strategies and Therapeutic Models. Final Progress Report for February 1, 2003 - July 31, 2003
R. F. Barth
The Ohio State University Research Foundation (United States)
2004